![David Hoey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Hoey
Director/Board Member at
UNIVERSAL BIOSENSORS, INC.
Profile
David L.
Hoey is currently Independent Non-Executive Director at Universal Biosensors, Inc. since 2016, Non-Executive Director at Universal Biosensors Pty Ltd. since 2016, Director at Universal Biosensors BV since 2021, and Director at Universal Biosensors LLC since 2021.
Former roles include President, Chief Executive Officer & Director at Vaxxas Pty Ltd. from 2012 to 2025, Chief Executive Officer & Director at Vaxxas, Inc., Director at Bligh Ventures Ltd., Director & Vice President-Business Development at PathoGenetix, Inc. from 2010 to 2012, Vice President-Business Development at Molten Metal Technology, Inc., and Vice President-Marketing & Business Development at InfoLibria, Inc.
David Hoey active positions
| Companies | Position | Start |
|---|---|---|
| UNIVERSAL BIOSENSORS, INC. | Director/Board Member | 02/03/2016 |
Universal Biosensors Pty Ltd.
 Universal Biosensors Pty Ltd. Medical SpecialtiesHealth Technology Manufactures diagnostic test systems | Director/Board Member | 01/03/2016 |
Universal Biosensors LLC | Director/Board Member | 31/08/2021 |
Universal Biosensors BV | Director/Board Member | 15/09/2021 |
Former positions of David Hoey
| Companies | Position | End |
|---|---|---|
Vaxxas, Inc.
 Vaxxas, Inc. Aerospace & DefenseElectronic Technology Part of Vaxxas Pty Ltd., Vaxxas, Inc. is a privately held biotechnology company focused on enhancing the performance of existing and next-generation vaccines with its proprietary high-density microarray patch (HD-MAP). The company is based in Cambridge, MA. Vaxxas is targeting initial applications in infectious disease and oncology. The CEO of the company is David L. Hoey. | Chief Executive Officer | 07/01/2026 |
Vaxxas Pty Ltd.
 Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Develops and commercializes needle-free vaccine delivery solutions | Chief Executive Officer | 25/08/2025 |
PathoGenetix, Inc.
 PathoGenetix, Inc. BiotechnologyHealth Technology Provides biological technological products and services | Director/Board Member | 01/10/2012 |
Bligh Ventures Ltd.
 Bligh Ventures Ltd. Investment Trusts/Mutual FundsMiscellaneous Provides management services and capital to enterprises | Director/Board Member | - |
Molten Metal Technology, Inc.
 Molten Metal Technology, Inc. Environmental ServicesIndustrial Services Engages in innovative and proprietary | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
25
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Molten Metal Technology, Inc.
Molten Metal Technology, Inc. Environmental ServicesIndustrial Services Engages in innovative and proprietary | Industrial Services |
Universal Biosensors, Inc.
 Universal Biosensors, Inc. Medical SpecialtiesHealth Technology Manufactures vitro diagnostic test devices | Health Technology |
InfoLibria, Inc.
 InfoLibria, Inc. Computer Processing HardwareElectronic Technology Develops and provides content distribution & communications hardware and software solutions | Electronic Technology |
PathoGenetix, Inc.
PathoGenetix, Inc. BiotechnologyHealth Technology Provides biological technological products and services | Health Technology |
Bligh Ventures Ltd.
Bligh Ventures Ltd. Investment Trusts/Mutual FundsMiscellaneous Provides management services and capital to enterprises | Miscellaneous |
Universal Biosensors Pty Ltd.
Universal Biosensors Pty Ltd. Medical SpecialtiesHealth Technology Manufactures diagnostic test systems | Health Technology |
Vaxxas Pty Ltd.
Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Develops and commercializes needle-free vaccine delivery solutions | Health Technology |
Vaxxas, Inc.
Vaxxas, Inc. Aerospace & DefenseElectronic Technology Part of Vaxxas Pty Ltd., Vaxxas, Inc. is a privately held biotechnology company focused on enhancing the performance of existing and next-generation vaccines with its proprietary high-density microarray patch (HD-MAP). The company is based in Cambridge, MA. Vaxxas is targeting initial applications in infectious disease and oncology. The CEO of the company is David L. Hoey. | Electronic Technology |
Universal Biosensors BV | |
Universal Biosensors LLC |
- Stock Market
- Insiders
- David Hoey
